Clinical trial Recruiting at 1 site Observational Ages 22 and up

TH-75 blood pressure monitor for detecting atrial fibrillation

Official title: Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

Run by Andon Health Co., Ltd · NCT07442175 · Data updated 2026-11-12

We will test whether the TH-75 blood pressure monitor can detect atrial fibrillation in adults with or without a prior AF diagnosis.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeObservational
Ages22 Years and up
SexAll
Enrollment392 (estimated)
SponsorAndon Health Co., Ltd
Industry-sponsored
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedFebruary 9, 2026
Main results expectedJune 30, 2026
Study endsJuly 30, 2026
Registry record updatedMarch 2, 2026
Trial IDNCT07442175 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 22 or older with arm circumference 22-42 cm who can cooperate with blood pressure and ECG measurements, whether they have a prior AF diagnosis or not.

Probably not a fit

Patients with implanted pacemakers or defibrillators, pregnant people, those with arm circumference outside 22-42 cm, or those unable to cooperate with measurements are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares readings from the TH-75 blood pressure monitor with a standard diagnostic method (ECG) to measure the device's accuracy for atrial fibrillation detection. Adults aged 22 and older with an arm circumference of 22-42 cm, both people diagnosed with AF and those without known AF, will have simultaneous device and ECG measurements. Participants who are pregnant, have an implanted pacemaker or defibrillator, or cannot cooperate with measurements will be excluded. The trial is conducted at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine in Tianjin, China.

Why it matters

Potential benefit: If accurate, the TH-75 could enable easier routine blood pressure checks to spot atrial fibrillation sooner and prompt timely care.

How similar studies have gone: Previous studies of blood-pressure devices with AF-detection algorithms have shown promising but variable accuracy, so device-specific testing is needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Atrial Fibrillation (AF):

* Age ≥ 22 years;
* Arm circumference between 22 cm and 42 cm;
* Diagnosed with atrial fibrillation by a qualified medical institution.

Non-Atrial Fibrillation:

* Age ≥ 22 years;
* Arm circumference between 22 cm and 42 cm;
* No prior diagnosis of atrial fibrillation.

Exclusion Criteria:

* Pregnant women
* Presence of an implanted cardiac pacemaker and/or defibrillator
* Inability to cooperate with blood pressure measurement or ECG assessment
* Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study

Where it's running

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.